LIVER INJURY IN COVID - 19
https://doi.org/10.24412/2790-1289-2021-13840
Abstract
An outbreak of previously unknown pneumonia caused by the novel coronavirus SARS-CoV-2 was first reported in Wuhan, China in December 2019. Currently, COVID-19 is considered a systemic disease with damage to various organs including the liver. However, the mechanism of liver damage in COVID - 19 is not well understood. There is a high mortality rate in patients with liver damage and concomitant COVID-19 which indicates an unfavorable outcome of the disease
About the Authors
T. V. Polukchi
South Kazakhstan Medical Academy
Kazakhstan
Kazakhstan
G. N. Abuova
South Kazakhstan Medical Academy
Kazakhstan
Kazakhstan
E. A. Slavko
Kazakh Medical university of сontinuing education
Kazakhstan
Kazakhstan
Candidate of Medical Sciences, Associate Professor
L. L. Sarypbekova
South Kazakhstan Medical Academy
Kazakhstan
Kazakhstan
T. V. Kasymova
South Kazakhstan Medical Academy
Kazakhstan
Kazakhstan
References
1. Clinical characteristics of coronavirus disease 2019 in China. Guan W.J., Ni Z.Y., Hu Y., et al. N Engl J Med. 2020; 382:1708–1720.
2. Jotwani R., Cheung C.A., Hoyler M.M. Trial under fire: one New York City anaesthesiology residency programme's redesign for the COVID-19 surge. Br J Anaesth. 2020;125:e386–e388.
3. Сандлер Ю.Г., Винницкая Е.В., Хайменова Т.Ю., Бордин Д.С. Клинические аспекты повреждения печени при COVID-19 // Эффективная фармакотерапия - Том 16- №15- С.18-23.
4. Xu L., Liu J., Lu M. et al. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020; 40 (5):998-1004. doi: 10.1111/liv.14435.
5. Chai X., Hu L., Zhang Y., et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020; 2020 (02):03.931766.
6. Melquist S., Estepp K., Aleksandrovich Y., Lee A., Beiseker A., Hamedani F.S., Bassett J. COVID-19 presenting as fulminant hepatic failure: A case report. Medicine (Baltimore). 2020 Oct 23; 99 (43):e22818. doi: 10.1097/ MD.0000000000022818.
7. Alqahtani S.A., Schattenberg J.M. Liver injury in COVID - 19: The current evidence. United European Gastroenterol J. 2020 Jun;8(5):509-519. doi: 10.1177/2050640620924157. PMID: 32450787; PMCID: PMC7268949.
8. Ильченко Л.Ю., Никитин И.Г., Федоров И.Г. COVID-19 и поражение печени // Архивъ внутренней медицины-2020.-Том 10-№ 3 (53) - С. 188-197.
9. Wu J., Song S., Cao H.C., Li L.J. Liver diseases in COVID-19: Etiology, treatment and prognosis. World J. Gastroenterol. 2020 May 21; 26 (19): 2286-2293. doi: 10.3748/wjg.v26.i19.2286.
10. Kumar R., Semaine W., Johar M., Tyrrell D.L., Agrawal B. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl) ethoxy) methyl] moiety, able to mimic natural 2 - deoxyribose, on wild-type and mutant hepatitis B virus replication. J Med Chem. 2006; 49: 3693–3700.
11. Zha L., Li S., Pan L., Tefsen B., Li Y., French N., Chen L., Yang G., Villanueva E.V. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19) Med J Aust. 2020.
12. Aghayari Sheikh Neshin S., Basirjafari S., Saberi A., Shahhosseini B., Zarei M. Liver abnormality may develop cerebral vein thrombosis in COVID-19. J Neurol Sci. 2020 Oct 15;417:117076. doi: 10.1016/j.jns.2020.117076. Epub 2020 Aug 5.
13. Melquist S., Estepp K., Aleksandrovich Y., Lee A., Beiseker A., Hamedani F.S., Bassett J. COVID-19 presenting as fulminant hepatic failure: A case report. Medicine (Baltimore). 2020 Oct 23;99 (43): e22818. doi: 10.1097/ MD.0000000000022818.
14. Makarem J., Naghibi N., Beigmohammadi M.T., Foroumandi M., Mehrpooya M.A. Case Report of Progressive Liver Failure Inappropriate to Decompensated Heart Failure Following Infection with COVID-19. Cureus. 2020 Aug 30;12(8): e10142. doi: 10.7759 / cureus.10142.
15. Shalimar, Elhence A., Vaishnav M., Kumar R., Pathak P., Soni K.D., Aggarwal R., Soneja M., Jorwal P., Kumar A., Khanna P., Singh A.K., Biswas A., Nischal N., Dar L., Choudhary A., Rangarajan K., Mohan A., Acharya P., Nayak B., Gunjan D., Saraya A., Mahapatra S., Makharia G., Trikha A., Garg P. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19. Indian J. Gastroenterol. 2020 Jun; 39(3):285-291. doi: 10.1007/s12664-020-01074-3. Epub 2020 Aug 15.
16. Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., Dong J., Zhao J., Wang F.S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420 - 422.
Review
For citations:
Polukchi T.V., Abuova G.N., Slavko E.A., Sarypbekova L.L., Kasymova T.V. LIVER INJURY IN COVID - 19. Actual Problems of Theoretical and Clinical Medicine. 2021;(1):38-40. (In Russ.) https://doi.org/10.24412/2790-1289-2021-13840
Views:
185
